A Narrative Review of Experimental Assessment to Study Vascular Biomaterials Infections and Infectability.
Biofilm
Infectability
Review
Vascular biomaterials
Vascular graft and endograft infections
Journal
EJVES vascular forum
ISSN: 2666-688X
Titre abrégé: EJVES Vasc Forum
Pays: England
ID NLM: 101766732
Informations de publication
Date de publication:
2023
2023
Historique:
received:
05
04
2022
revised:
23
03
2023
accepted:
09
05
2023
medline:
6
7
2023
pubmed:
6
7
2023
entrez:
6
7
2023
Statut:
epublish
Résumé
Many experimental studies have been conducted to evaluate vascular and endovascular graft infections (VGEIs) and infectability in order to elaborate strategies to prevent or to treat their occurrence. A systematic literature search was conducted to collect and summarise key features of infection and infectability assessment techniques in VGEI experimental models. The literature search was conducted using the Medline and Cochrane databases, with no limit on the date of publication, until 10 August 2021. A total of 243 studies were included in the review: 55 Many experimental tools are available to study VGEIs, but to improve their reproducibility and scientific reliability research protocols must be standardised and include sonication of grafts before microbiological culture. Moreover, the key role of the biofilm in VGEI physiopathology must be taken into account in future studies.
Identifiants
pubmed: 37408851
doi: 10.1016/j.ejvsvf.2023.05.002
pii: S2666-688X(23)00050-3
pmc: PMC10319211
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
49-55Informations de copyright
© 2023 Published by Elsevier Ltd on behalf of European Society for Vascular Surgery.
Références
Antimicrob Agents Chemother. 2012 Dec;56(12):6310-8
pubmed: 23027191
J Surg Res. 1992 Oct;53(4):384-90
pubmed: 1405618
J Vasc Surg. 2021 Oct;74(4):1386-1393.e1
pubmed: 34019984
J Vasc Surg. 2007 Nov;46(5):1026-31
pubmed: 17905555
Eur J Vasc Endovasc Surg. 2020 Mar;59(3):339-384
pubmed: 32035742
Antimicrob Agents Chemother. 2014 Nov;58(11):6660-7
pubmed: 25155589
Eur J Vasc Endovasc Surg. 2020 Aug;60(2):253
pubmed: 32278638
J Orthop Res. 2008 Jan;26(1):96-105
pubmed: 17676625
Ann Vasc Surg. 2001 Jul;15(4):421-9
pubmed: 11525531
Eur J Vasc Endovasc Surg. 2011 Jan;41(1):68-75
pubmed: 20943422
Antimicrob Agents Chemother. 2015 Apr;59(4):2029-36
pubmed: 25605365
J Infect Dis. 2003 Feb 15;187(4):625-30
pubmed: 12599079
J Surg Res. 1988 Jan;44(1):1-7
pubmed: 3336207
J Thorac Cardiovasc Surg. 1970 May;59(5):635-7
pubmed: 4909253
Ann Vasc Surg. 1996 May;10(3):244-53
pubmed: 8792993
J Vasc Surg. 1986 May;3(5):732-40
pubmed: 2939263
J Antimicrob Chemother. 2016 May;71(5):1291-9
pubmed: 26851611
N Engl J Med. 2007 Aug 16;357(7):654-63
pubmed: 17699815
J Surg Res. 2018 Jan;221:143-151
pubmed: 29229120
Am J Pathol. 2017 Feb;187(2):268-279
pubmed: 28088288
J Microbiol Methods. 2000 Apr;40(2):175-9
pubmed: 10699673
Microbiol Immunol. 1999;43(4):317-21
pubmed: 10385197
J Antimicrob Chemother. 2018 Sep 1;73(9):2418-2421
pubmed: 29901764
Eur J Vasc Endovasc Surg. 2018 Oct;56(4):562-571
pubmed: 30076076
Surgery. 1975 Aug;78(2):211-6
pubmed: 125460
J Biomater Appl. 1991 Jan;5(3):227-46
pubmed: 1826531
Front Microbiol. 2017 Dec 05;8:2333
pubmed: 29259580
Syst Rev. 2015 Jan 01;4:1
pubmed: 25554246
Aust N Z J Surg. 1990 Oct;60(10):801-3
pubmed: 2144960
J Surg Res. 1998 Jan;74(1):17-22
pubmed: 9536967
J Vasc Surg. 1994 Apr;19(4):675-82
pubmed: 8164283
J Antimicrob Chemother. 2000 Nov;46(5):751-6
pubmed: 11062194
J Med Microbiol. 2019 Mar;68(3):432-439
pubmed: 30735113
EJVES Vasc Forum. 2022 Mar 15;55:30-37
pubmed: 35434684
Eur J Vasc Endovasc Surg. 2019 Mar;57(3):424-432
pubmed: 30301647
Biomaterials. 2010 Mar;31(8):1984-95
pubmed: 19969345
Am Surg. 1991 Mar;57(3):161-4
pubmed: 1825907
J Vasc Surg. 1989 May;9(5):665-70
pubmed: 2524605
Eur J Vasc Endovasc Surg. 2021 Jul;62(1):99-118
pubmed: 33840577
Arch Surg. 1987 Jan;122(1):38-43
pubmed: 3541853